DOW
30
2
MS
80
-3
XEL
65
-2
AMAT
43
-5
TXT
62
2
MAT
38
-3
PSA
58
5
PG
50
2
DGX
48
-3
IVZ
49
-3
GOOGL
59
-8
STI
31
19
SCHW
65
-2
GOOG
69
-10
LOW
58
2
KEY
46
-2
STZ
58
3
PAYX
57
-2
LRCX
46
-2
SLG
62
-4
DOW
30
2
MS
80
-3
XEL
65
-2
AMAT
43
-5
TXT
62
2
MAT
38
-3
PSA
58
5
PG
50
2
DGX
48
-3
IVZ
49
-3
GOOGL
59
-8
STI
31
19
SCHW
65
-2
GOOG
69
-10
LOW
58
2
KEY
46
-2
STZ
58
3
PAYX
57
-2
LRCX
46
-2
SLG
62
-4
Financhill
Back

Replimune Group 10K Form

Sell
36

REPL
Replimune Group

Last Price:
11.40
Seasonality Move:
-9.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive REPL News And Ratings

See the #1 stock for the next 7 days that we like better than REPL

REPL Financial Statistics

Sales & Book Value

Annual Sales: $4.95K
Cash Flow: $-50.84M
Price / Cash Flow: 0
Annual Sales: $6.24
Price / Book: 1.95

Profitability

EPS (TTM): -3.27000
Net Income (TTM): $-220.01M
Gross Margin: $4.95K
Return on Equity: 0%
Return on Assets: 0%

Replimune Group Earnings Forecast

Key Replimune Group Financial Ratios

  • The Gross Profit Margin over the past 1 years for REPL is 100.00%.
  • The Selling, General & Administrative Expenses for REPL have been equal to 1,021,272.73% of Gross Profit Margin.
  • The Interest Expense is -3.09% of Operating Income.
  • Per Share Earnings over the last 8 years have been positive in 1 years.

Replimune Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: REPL
CUSIP: 76029N
Website: replimune.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

REPL Technical Analysis vs Fundamental Analysis

Sell
36
Replimune Group (REPL) is a Sell

Is Replimune Group a Buy or a Sell?

  • Replimune Group stock is rated a Sell
    The current Replimune Group [REPL] share price is $11.69. The Score for REPL is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.